PonatinibN-Oxide

PonatinibN-Oxide Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

Ponatinib N-Oxide is derived from Ponatinib (P688250), which is a tyrosine kinase inhibitors (TKI) and used to treat chronic myeloid leukemia (CML) (1,2,3). Ponatinib is also used in combination with other drugs, such as forskolin, to combat TKI resistance in patient with CML (3), targeted drug in small-cell lung cancer. Potent FAK inhibitor. FGFR/VEGFR/Bcr-Abl inhibitor. It is a COVID19-related research product.

PonatinibN-Oxide Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

PonatinibN-Oxide Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Nanjing XiZe Biotechnology CO., Ltd.	025-58362220 15250997978	1511893459@qq.com	China	7774	55
United States Biological	--	sales@advtechind.com	United States	6106	58

---

• PonatinibN-Oxide